Prostate-Specific Membrane Antigen-Based Therapeutics

Prostate-Specific Membrane Antigen-Based Therapeutics

Prostate cancer (PC) is the most common noncutaneous malignancy affecting men in the US, leading to significant morbidity and mortality. While significant therapeutic advances have been made, available systemic therapeutic options are lacking. Prostate-specific membrane antigen (PSMA) is a highly-re...

Full description

Saved in:

Bibliographic Details
Main Authors:	Naveed H. Akhtar, Orrin Pail, Ankeeta Saran, Lauren Tyrell, Scott T. Tagawa
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	Advances in Urology
Online Access:	http://dx.doi.org/10.1155/2012/973820
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prostate-Specific Membrane Antigen as Target for Neuroimaging of Central Nervous System Tumors
by: Brittany M. Stopa, et al.
Published: (2022-01-01)

The Current Role of Androgen Deprivation in Patients Undergoing Dose-Escalated External Beam Radiation Therapy for Clinically Localized Prostate Cancer
by: Michael J. Smith, et al.
Published: (2012-01-01)

High Detection Rates for Prostate-specific Membrane Antigen–avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography
by: Sarah Thomas, et al.
Published: (2025-01-01)

Radiochemistry and Preclinical PET Imaging of Ga-Desferrioxamine Radiotracers Targeting Prostate-Specific Membrane Antigen
by: Eleni Gourni PhD, et al.
Published: (2017-10-01)

Prostate-specific Antigen as a Predictor for the Diagnosis of Prostate Adenocarcinoma
by: Wilfredo Valiente Morejón, et al.
Published: (2015-11-01)

Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01)

Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma
by: Ilham Badrane, et al.
Published: (2024-12-01)

Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
by: Yuxuan Chen, et al.
Published: (2025-01-01)

Association between prostate-specific antigen density and prostate cancer prediction among Nigerian men
by: Abudu EK, et al.
Published: (2025-01-01)

Chikungunya Virus Infection and Acute Elevation of Serum Prostate-Specific Antigen
by: William Derval Aiken, et al.
Published: (2015-01-01)

Value of Systematic and MRI‐Ultrasound Fusion Prostate Biopsy in Different Prostate Specific Antigen (PSA) Levels
by: Solmaz Ohadian Moghadam, et al.
Published: (2025-01-01)

The Prognostic Importance of Prostate-Specific Antigen in Monitoring Patients Undergoing Maximum Androgen Blockage for Metastatic Prostate Cancer
by: Ahmet Kiper, et al.
Published: (2005-01-01)

Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions
by: Yongming Jin, et al.
Published: (2025-01-01)

18F−Prostate−Specific Membrane Antigen PET/CT imaging for potentially resectable pancreatic cancer (PANSCAN−2): a phase I/II study
by: Jisce R. Puik, et al.
Published: (2025-01-01)

Diagnostic Accuracy of Serum Prostate Specific Antigen and Gleason Score in Determining the Presence of Skeletal Metastasis in Prostate Cancer Patients: a Pakistani Perspective
by: Taimoor Nasir, et al.
Published: (2023-04-01)

An MRI radiomics model for predicting a prostate-specific antigen response following abiraterone treatment in patients with metastatic castration-resistant prostate cancer
by: Yi Wu, et al.
Published: (2025-01-01)

Relationship between albumin-globulin ratio and prostate-specific antigen: a cross-sectional study based on NHANES 2003–2010
by: Simeng Gao, et al.
Published: (2025-01-01)

Hubungan Usia dan Kadar Prostate Specific Antigen (PSA) dengan Derajat Histopatologi Adenokarsinoma Prostat di RSUD Abdoel Wahab Sjahranie Samarinda
by: Novita Eka Tyas Pratiwi, et al.
Published: (2023-10-01)

Influence of Regular Statin Intake on Prostate‐Specific Antigen Values, Prostate Cancer Incidence and Overall Survival in a Prospective Screening Trial (ERSPC Aarau)
by: Alkiviadis Papagiannakis, et al.
Published: (2025-01-01)

A Sensitive Fluorescent Immunoassay for Prostate Specific Antigen Detection Based on Signal Amplify Strategy of Horseradish Peroxidase and Silicon Dioxide Nanospheres
by: Lihua Li, et al.
Published: (2022-01-01)

Update on New Antigens in the Pathogenesis of Membranous Nephropathy
by: Maurizio Salvadori, et al.
Published: (2022-09-01)

Expression of Neutral Endopeptidase, Endothelin-1, and Nuclear Factor Kappa B in Prostate Cancer: Interrelations and Associations with Prostate-Specific Antigen Recurrence after Radical Prostatectomy
by: Panagiotis J. Vlachostergios, et al.
Published: (2012-01-01)

Diagnostic accuracy of 18F Prostate Specific Membrane Antigen (PSMA) PET-CT radiotracers in staging and restaging of high-risk prostate cancer patients and patients with biochemical recurrence: protocol for an overview of reviews [version 2; peer review: 2 approved]
by: Susan Ahern, et al.
Published: (2025-01-01)

Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of real-world practice of urologists in Spain and Brazil
by: Juan Manuel Palacios, et al.
Published: (2025-01-01)

Immunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigens.
by: Guidenn Sulbarán, et al.
Published: (2013-01-01)

Autoimmune Cholangitis in the SJL/J Mouse is Antigen Non-specific
by: Motoko Sasaki, et al.
Published: (2002-01-01)

Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies
by: Tilahun Alelign, et al.
Published: (2018-01-01)

Specific immunohistochemical expression of Mmp-26 in prostatic adenocarcinoma
by: ROMILDO LUCIANO DA SILVA, et al.
Published: (2025-01-01)

New Therapeutics to Treat Castrate-Resistant Prostate Cancer
by: Ömer Acar, et al.
Published: (2013-01-01)

Prostate Cancer
by: Scott Eggener
Published: (2011-01-01)

Studies on the Induction of Antigen-Specific Antibody in Anti-CD40 Cultured Human B Lymphocytes
by: B. M. Schilizzi, et al.
Published: (1998-01-01)

Editorial: Specific targeting of MHC antigens for T-cells and immune cells in human disease
by: Ali Afzal, et al.
Published: (2025-01-01)

Cell-Specific Aptamers as Emerging Therapeutics
by: Cindy Meyer, et al.
Published: (2011-01-01)

Specific therapeutic options for transthyretin amyloidosis
by: Zoltán Pozsonyi
Published: (2024-12-01)

Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor Antigen
by: Boya Zhong, et al.
Published: (2015-01-01)

Efficient Predictor for Immunotherapy Efficacy: Detecting Pan‐Clones Effector Tumor Antigen‐Specific T Cells in Blood by Nanoparticles Loading Whole Tumor Antigens
by: Weibiao Zeng, et al.
Published: (2025-01-01)

AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer
by: Guansong Zheng, et al.
Published: (2025-02-01)

Multilevel Precision-Based Rational Design of Chemical Inhibitors Targeting the Hydrophobic Cleft of Apical Membrane Antigen 1 (AMA1)
by: Umashankar Vetrivel, et al.
Published: (2016-06-01)

Preparation of specific components of Elisa test-system for detection of Schmallenberg desease virus antigens
by: O. G. Gubenko, et al.
Published: (2018-04-01)

Tumor-specific cytosol-penetrating antibodies for antigen- and TME-dependent intracellular cargo delivery
by: Carolin Sophie Dombrowsky, et al.
Published: (2025-03-01)